News - Latest
74 news items
Sort by: Date / Relevance
Amended policy for DHPCs and national implementation of additional risk minimisation measures
The Medicines Evaluation Board (MEB) has amended its policy for Direct Healthcare Professional Communications (DHPCs) and the ...
The fourth issue of Regulatory Science Magazine is being launched today
The fourth issue of the Medicines Evaluation Board’s Regulatory Science Magazine is appearing today. The focus this time is on ...
MEB and Dutch Heart Foundation to collaborate on making medicines available to the patient more quickly
Scientific advice from the MEB improves and speeds up the development of medicines The Medicines Evaluation Board (MEB) is going ...
Signal management pilot for limited group of companies
On 22 February 2018 a pilot will start for companies with medicinal products under additional monitoring. As from that date ...
Involve quality and safety in the discussion about medicines
The Medicines Evaluation Board (MEB) believes that the discussion about expensive medicines should not just focus on costs. ...
Report side effects of veterinary medicines
Last week, the Medicines Evaluation Board (MEB) called for more attention in reporting possible side effects of medicines. ...
Olaf Dekkers sworn in as a new MEB member
Prof. O.M. (Olaf) Dekkers was sworn in as a new member of the Medicines Evaluation Board (MEB) on 23 November 2017.
MEB delighted about the EMA move to Amsterdam
The Medicines Evaluation Board (MEB) is pleased to welcome the European Medicines Agency (EMA) to Amsterdam. In its declaration ...
Launch of 3rd edition of Regulatory Science Magazine during farewell symposium for Christine Gispen-de Wied
On Wednesday 1 November 2017 a mini symposium was organised to mark the retirement of Dr Christine Gispen-de Wied, manager of the ...
National policy for labelling of medicinal products amended
The MEB has adapted the policy on labelling of medicinal products for human use. Information on this policy is contained in ...